# A Study of Oral Contraception Under Simulated OTC Conditions

> **NCT03559010** · PHASE3 · TERMINATED · sponsor: **HRA Pharma** · enrollment: 189 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Norgestrel 0.075 mg tablets

## Key facts

- **NCT ID:** NCT03559010
- **Lead sponsor:** HRA Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-27
- **Primary completion:** 2018-09-09
- **Final completion:** 2018-11-14
- **Target enrollment:** 189 (ACTUAL)
- **Why stopped:** Terminated prematurely due to issues with one of the data collection systems, no impact on subject safety
- **Last updated:** 2022-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03559010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03559010, "A Study of Oral Contraception Under Simulated OTC Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03559010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*